A detailed history of Rathbones Group PLC transactions in Zoetis Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 402,128 shares of ZTS stock, worth $66.2 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
402,128
Previous 398,009 1.03%
Holding current value
$66.2 Million
Previous $69 Million 13.87%
% of portfolio
0.41%
Previous 0.39%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $710,857 - $809,301
4,119 Added 1.03%
402,128 $78.6 Million
Q2 2024

Aug 09, 2024

BUY
$145.54 - $178.83 $7.31 Million - $8.98 Million
50,195 Added 14.43%
398,009 $69 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $6.53 Million - $7.88 Million
39,399 Added 12.77%
347,814 $58.9 Million
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $9.86 Million - $13 Million
65,130 Added 26.77%
308,415 $60.9 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $20.5 Million - $23.6 Million
122,619 Added 101.62%
243,285 $42.3 Million
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $249,296 - $288,470
1,549 Added 1.3%
120,666 $20.8 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $290 - $350
2 Added 0.0%
119,117 $19.8 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $99,535 - $119,519
759 Added 0.64%
119,115 $17.5 Million
Q3 2022

Nov 03, 2022

BUY
$148.29 - $182.55 $94,164 - $115,919
635 Added 0.54%
118,356 $17.6 Million
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $72,837 - $93,442
467 Added 0.4%
117,721 $20.2 Million
Q1 2022

May 11, 2022

BUY
$181.39 - $234.03 $107,564 - $138,779
593 Added 0.51%
117,254 $22.1 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $693,991 - $885,108
3,583 Added 3.17%
116,661 $28.5 Million
Q3 2021

Nov 04, 2021

BUY
$189.29 - $209.69 $43,725 - $48,438
231 Added 0.2%
113,078 $22 Million
Q2 2021

Jul 30, 2021

BUY
$155.9 - $187.99 $124,408 - $150,016
798 Added 0.71%
112,847 $21 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $3.05 Million - $3.59 Million
21,202 Added 23.34%
112,049 $17.6 Million
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $344,297 - $382,175
2,192 Added 2.47%
90,847 $15 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $171,786 - $207,208
1,253 Added 1.43%
88,655 $14.7 Million
Q2 2020

Aug 07, 2020

BUY
$111.92 - $142.53 $153,666 - $195,693
1,373 Added 1.6%
87,402 $12 Million
Q1 2020

May 04, 2020

BUY
$92.66 - $144.94 $117,863 - $184,363
1,272 Added 1.5%
86,029 $10.1 Million
Q4 2019

Feb 11, 2020

BUY
$116.25 - $133.25 $3.14 Million - $3.6 Million
27,034 Added 46.83%
84,757 $11.2 Million
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $6.5 Million - $7.41 Million
57,723 New
57,723 $7.19 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.